Make in India
Amit Sehgal, Managing Director, Avantor India, explains how ‘Make in India’ recognises ‘ease of doing business’ as one of the most…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
COVID virus and vaccines … a review
Siddhartha Mitra, retired pharma professional, reviews the doubts, controversies and unexplained fears about COVID-19 and the…
Understanding the sources, properties and benefits of squalene
Dr Kumara Panicker Gopakumar, Scientist, TheLifekart.in, explains the various roles played by squalene in human body
Staying ahead of the curve by simplifying drug delivery
Drug delivery systems, in the Indian context, needs to be seen in a new light that takes into account a lot many things, including…
How pharma laws impacted the production and distribution of COVID-19 vaccine
Rajdutt Shekhar Singh, Partner, and Mohit Mansharamani, Associate, Singh & Associates, explain the impact of pharma laws on…
Branding strategies for Indian nutraceutical industry
While there is rarely a one-size-fits-all formula to branding, Sushil Khaitan, founder and MD, Pure Nutrition, jots down a few…
Increased emphasis on HCP engagement rules in new normal
Sanjay Mehta, Jt CEO, Mirum, explains several ways for pharma companies that would help those in engaging healthcare professionals…
How nutra industry is driving Indian GDP forward
Sanjaya Mariwala, Founder President, Association of Herbal and Nutraceuticals Manufacturers of India (AHNMI) and Executive…
Building an effective cold-chain network for grass-root vaccinations in India
Anuraaga Chandra, Head, India Sales, Danfoss Climate Solutions explains about the need for diversifying the cold-chain…
Simulation technology for pharma and biopharma
Rafiq Somani, Area Vice President – India and South Asia Pacific, Ansys, explains why simulation technology is a win-win for…
AI and ML hold answers for Indian pharma’s logistics challenges
Rahul Vishwakarma, Co-founder and CEO, Mate Labs, asserts that deploying Artificial Intelligence (AI) and Machine Learning (ML) at…
Biocon Biologics-SII alliance should balance business and public health
As both leaders hint at the intangibles of the alliance, let's hope they make good their promise to both patients as well as…
Will personal care and hygiene brands, nutraceuticals be the fallback of pharma companies as price…
Reetesh Dhingra, Co-founder, WiZ, explains why pharmaceutical companies are losing their ground and how these are finding solace…
A Superstar marriage?
Chandru Chawla, a pharma veteran, opines that Biocon and SII coming together is a milestone event in the evolution of Indian…
Nutraceuticals: The need for strong regulation
Rutu Dhodapkar, Dietetics Department, P D Hinduja Hospital and Medical Research Centre, Khar explains the importance of…
Why Ayurveda and herbal products should be in capsules
Dr Milind Biyani, MPharm, PhD (Tech), R&D Director, Aspire Advisors, elucidates on the importance of using Ayurveda and herbal…
Impact of COVID-19 and regulations for OTC segment
Many pharma companies are inclined to capture the OTC market in India due to the high consumer ratio, but COVID has shifted the…
AI’s role in revolutionising the logistics in the post-pandemic era
Soham Chokshi, Founder and CEO, Shipsy shares insights on how AI helps tackle the logistics challenges posed by COVID-19 by…
Three tips by tech leaders in pharma: Navigating through turbulence in 2021
The growing interest of global players and investors in the Indian pharma sector spells that the sector is all set to soar further…
Cross-border product liability claims
Sanjay Kumar, Counsel,J Sagar Associates, sheds light on how globalisation has led to a blurring of boundaries, and, thus, with…